Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia
References
- Pasricha S. Anemia: a comprehensive global estimate. Blood. 2014; 123(5): 611–612. DOI: 10.1182/blood-2013-12-543405
- Tang Y, Katz S. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes. Heart Failure Reviews. 2008; 13(4): 387–392. DOI: 10.1007/s10741-008-9089-7
- Klip I, Comin-Colet J, Voors A, et al. Iron deficiency in chronic heart failure: An international pooled analysis. American Heart Journal. 2013; 165(4): 575–582.e3. DOI: 10.1016/j.ahj.2013.01.017
- Ponikowski P, Voors A, Anker S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016; 18(8): 891–975. DOI: 10.1002/ejhf.592
- Jankowska E, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal. 2010; 31(15): 1872–1880. DOI: 10.1093/eurheartj/ehq158
- Aung N, Ling H, Cheng A, et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. International Journal of Cardiology. 2013; 168(3): 1997–2002. DOI: 10.1016/j.ijcard.2012.12.091
- Okonko D, Mandal A, Missouris C, Poole-Wilson P. Disordered Iron Homeostasis in Chronic Heart Failure. Journal of the American College of Cardiology. 2011; 58(12): 1241–1251. DOI: 10.1016/j.jacc.2011.04.040
- Anker S, Comin Colet J, Filippatos G, et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. New England Journal of Medicine. 2009; 361(25): 2436–2448. DOI: 10.1056/NEJMoa0908355
- Beck-da-Silva L, Piardi D, Soder S, et al. IRON-HF study: A randomized trial to assess the effects of iron in heart failure patients with anemia. International Journal of Cardiology. 2013; 168(4): 3439–3442. DOI: 10.1016/j.ijcard.2013.04.181
- Langer A, Ginzburg Y. Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation. Hemodialysis International. 2017; 21: S37–S46. DOI: 10.1111/hdi.12543
- Lakhal-Littleton S, Wolna M, Chung Y, et al. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. eLife. 2016; 5. DOI: 10.7554/eLife.19804
- Nemeth E. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization. Science. 2004; 306(5704): 2090–2093. DOI: 10.1126/science.1104742
- Franchini M, Montagnana M, Lippi G. Hepcidin and iron metabolism: From laboratory to clinical implications. Clinica Chimica Acta. 2010; 411(21–22): 1565–1569. DOI: 10.1016/j.cca.2010.07.003
- Niehaus E, Malhotra R, Cocca-Spofford D, Semigran M, Lewis G. Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure. Journal of Cardiac Failure. 2015; 21(8): 694–697. DOI: 10.1016/j.cardfail.2015.05.006
- Ponikowski P, van Veldhuisen D, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal. 2014; 36(11): 657–668. DOI: 10.1093/eurheartj/ehu385
- von Haehling S, Anker M, Jankowska E, Ponikowski P, Anker S. Anemia in chronic heart failure: Can we treat? What to treat? Heart Failure Reviews. 2011; 17(2): 203–210. DOI: 10.1007/s10741-011-9283-x
- Saxena G, Khera P, Jain D. Role of Hepcidin in Heart Failure with Iron Deficiency – Deception or Disposition. J Assoc Physicians India. April 2019; 67(4): 53–56.
- De Las Nieves MA. Should oral iron be dismissed in patients with heart failure? BMJ Evid Based Med. October 2020; 25(5): 155–156. Epub 2019 Jul 10. DOI: 10.1136/bmjebm-2019-111198
- Jankowska E, Malyszko J, Ardehali H, et al. Iron status in patients with chronic heart failure. European Heart Journal. 2012; 34(11): 827–834. DOI: 10.1093/eurheartj/ehs377
- Divakaran V, Mehta S, Yao D, et al. Hepcidin in anemia of chronic heart failure. Am J Hematol. January 2011; 86(1): 107–9. DOI: 10.1002/ajh.21902
- Matsumoto M, Tsujino T, Lee-Kawabata M, et al. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia. Circ J. February 2010; 74(2): 301–6. DOI: 10.1253/circj.CJ-09-0663
- Lewis G, Malhotra R, Hernandez A, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency. JAMA. 2017; 317(19): 1958. DOI: 10.1001/jama.2017.5427
- Saha L, Pandhi P, Gopalan S, Malhotra S, Saha PK. Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women. MedGenMed. 2 January 2007; 9(1): 1.
- Mischler RA, Armah SM, Craig BA, et al. Comparison of Oral Iron Supplement Formulations for Normalization of Iron Status Following Roux-EN-y Gastric Bypass Surgery: a Randomized Trial. Obes Surg. February 2018; 28(2): 369–377. DOI: 10.1007/s11695-017-2858-4
- Zdravkovic S, Nagorni S, Cojbasic I, et al. Journal of International Medical Research. 2019; 47(7): 3179–3189. DOI: 10.1177/0300060519847352
- Powers J, Buchanan G, Adix L, Zhang S, Gao A, McCavit T. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia. JAMA. 2017; 317(22): 2297. DOI: 10.1001/jama.2017.6846
DOI: https://doi.org/10.5334/gh.1151 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 20, 2022
Accepted on: Aug 4, 2022
Published on: Nov 22, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Lita Dwi Suryani, Sunu Budhi Raharjo, Rima Sagita, Hansen Angkasa, Yosafat Lambang Prasetyadi, Franciscus D. Suyatna, Nani Hersunarti, Rarsari Soerarso, Bambang Budi Siswanto, Hary Sakti Muliawan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.